Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinomaYing Jiang, Fuchu He, Aihua Sun et al.|Nature|2019Cited by 982
Integrative Proteomic Characterization of Human Lung AdenocarcinomaJun‐Yu Xu, Minjia Tan, Zhiwei Liu et al.|Cell|2020Cited by 634
Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78Zhiwen Gu, Aihua Sun, Lei Wang et al.|Proceedings of the National Academy of Sciences|2023Cited by 37
The coming era of proteomics-driven precision medicineYing Jiang, Fuchu He, Jian Wang et al.|National Science Review|2025Cited by 22